Cell Biotech Overview

  • Founded
  • 1995

Founded
  • Status
  • Public

  • Employees
  • 123

Employees
  • Stock Symbol
  • 049960

Stock Symbol
  • Share Price
  • $10.97

  • (As of Wednesday Closing)

Cell Biotech General Information

Description

Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
KRX
Primary Office
  • 397, Aegibong-ro
  • Wolgot-Myeon
  • Gimpo, Gyeonggi 415-872
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Biotech Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.97 $11.18 $7.23 - $14.63 $75.1M 6.84M 12.4K $1.69

Cell Biotech Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 8,393 64,110 103,253 68,026
Revenue 39,072 40,922 38,606 39,414
EBITDA 15,439 12,937 4,604 8,692
Net Income 11,734 9,065 2,701 6,201
Total Assets 83,071 94,853 96,525 93,498
Total Debt 764 694 1,233 799
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cell Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cell Biotech‘s full profile, request access.

Request a free trial

Cell Biotech Patents

Cell Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3845632-A1 Composition for promoting the growth of lactic acid bacteria comprising growth factors Pending 02-Jan-2020 00000000 0
US-20210207077-A1 Composition for promoting the growth of lactic acid bacteria comprising growth factors Pending 02-Jan-2020 00000000 0
EP-3824743-A1 Composition for preventing, relieving or treating climacteric disorders comprising lactic acid bacteria and isoflavone comprising soybean germ extract Pending 25-Nov-2019 000000000 0
US-20210204583-A1 Composition for preventing, relieving or treating climacteric disorders comprising lactic acid bacteria and prebiotics Pending 25-Nov-2019 000000000 0
EP-3725161-A1 Method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using protein hydrolysate Pending 15-Apr-2019 C12N1/20
To view Cell Biotech’s complete patent history, request access »

Cell Biotech Executive Team (1)

Name Title Board Seat Contact Info
Myung-Jun Chung Ph.D Chief Executive Officer
To view Cell Biotech’s complete executive team members history, request access »

Cell Biotech Board Members (1)

Name Representing Role Since
00000 0000 Cell Biotech Board Member 000 0000
To view Cell Biotech’s complete board members history, request access »

Cell Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cell Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cell Biotech‘s full profile, request access.

Request a free trial

Cell Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Cell Biotech’s complete esg history, request access »